{
    "clinical_study": {
        "@rank": "109227", 
        "arm_group": [
            {
                "arm_group_label": "HGE(hydrolyzed ginseng extract)", 
                "arm_group_type": "Experimental", 
                "description": "HGE capsules(2cap/d, 960mg/d) for 8 weeks."
            }, 
            {
                "arm_group_label": "Placebo", 
                "arm_group_type": "Placebo Comparator", 
                "description": "Placebo for 8 weeks"
            }
        ], 
        "brief_summary": {
            "textblock": "This study was conducted to investigate the effects of daily supplementation of hydrolyzed\n      ginseng extract(HGE) on glycemic status in subjects with impared fasting glucose(IFG)."
        }, 
        "brief_title": "Efficacy and Safety of Hydrolyzed Ginseng Extract on Impaired Fasting Glucose", 
        "completion_date": {
            "#text": "December 2009", 
            "@type": "Actual"
        }, 
        "condition": "Hyperglycemia", 
        "condition_browse": {
            "mesh_term": "Hyperglycemia"
        }, 
        "detailed_description": {
            "textblock": "This study was a 8 weeks, randomized, double-blind, placebo-controlled trial. Twenty\n      subjects were randomly divided into HGE or a placebo group. Fasting and postprandial glucose\n      profiles during OGTT were assessed before and after the intervention."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Age 20-70 years with fasting glucose 100~126 mg/dL\n\n        Exclusion Criteria:\n\n          -  Abnormal lipid profile values\n\n          -  Acute/chronic inflammation\n\n          -  Treated with corticosteroid within past 4 weeks\n\n          -  Cardiovascular disease\n\n          -  Allergic or hypersensitive to any of the ingredients in the test products\n\n          -  History of disease that could interfere with the test products or impede their\n             absorption\n\n          -  Participation in any other clinical trials within past 2 months\n\n          -  Renal disease\n\n          -  Abnormal hepatic function\n\n          -  Under hypolipidemic drugs therapy within past 3 months\n\n          -  Under antipsychotic drugs therapy within past 2 months\n\n          -  Laboratory test, medical or psychological conditions deemed by the investigators to\n             interfere with successful participation in the study\n\n          -  History of alcohol or substance abuse\n\n          -  Pregnancy or breast feeding"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "70 Years", 
            "minimum_age": "20 Years"
        }, 
        "enrollment": {
            "#text": "20", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "May 13, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01854164", 
            "org_study_id": "Ilhwa-FG-001"
        }, 
        "intervention": [
            {
                "arm_group_label": "HGE(hydrolyzed ginseng extract)", 
                "intervention_name": "HGE (hydrolyzed ginseng extract)", 
                "intervention_type": "Dietary Supplement"
            }, 
            {
                "arm_group_label": "Placebo", 
                "intervention_name": "Placebo", 
                "intervention_type": "Dietary Supplement"
            }
        ], 
        "is_fda_regulated": "No", 
        "keyword": "HGE, impaired fasting glucose, clinical trial", 
        "lastchanged_date": "May 13, 2013", 
        "location": {
            "facility": {
                "address": {
                    "city": "Jeonju", 
                    "country": "Korea, Republic of", 
                    "state": "Jeollabuk-do", 
                    "zip": "560-822"
                }, 
                "name": "Clinical Trial Center for Functional Foods, Chonbuk National University Hospital"
            }
        }, 
        "location_countries": {
            "country": "Korea, Republic of"
        }, 
        "number_of_arms": "2", 
        "official_title": "An 8 Weeks, Randomized, Double-blind, Placebo-controlled Clinical Trial for Anti-diabetic Effects of Hydrolyzed Ginseng Extract", 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "South Korea: Institutional Review Board", 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "December 2009", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "description": "Changes of fasting and postprandial glucose during OGTT were assessed before(baseline) and after the intervention.", 
            "measure": "Changes of blood glucose during OGTT(oral glucose tolerence test)", 
            "safety_issue": "Yes", 
            "time_frame": "8 weeks"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01854164"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Chonbuk National University Hospital", 
            "investigator_full_name": "Soo-Wan Chae", 
            "investigator_title": "Principal Investigator, Clinical Trial Center for Functional Foods", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": [
            {
                "description": "Changes of blood insulin during OGTT were assessed before(baseline) and after the intervention.", 
                "measure": "Changes of blood insulin during OGTT.", 
                "safety_issue": "Yes", 
                "time_frame": "8 weeks"
            }, 
            {
                "description": "Changes of glycated albumin, fructosamine, and lipid profile were assessed before(baseline) and after the intervention", 
                "measure": "Changes of glycated albumin, fructosamine, and lipid profile", 
                "safety_issue": "Yes", 
                "time_frame": "8 weeks"
            }
        ], 
        "source": "Chonbuk National University Hospital", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Chonbuk National University Hospital", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "June 2009", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Prevention", 
        "study_type": "Interventional", 
        "verification_date": "May 2013"
    }
}